CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $6.92B, above the global median of $1.15B
- FinancialsAltman Z-Score 5.69: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.11%Below 5Y avg (0.34%)
Annual Rate
INR 2.50Paid annual
Payout Ratio
7.8%Sustainable
Last Ex-Dividend
Aug 31, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
656.37BINR6.92B · vs all stocks (USD)
Trailing P/E
36.46xRevenue (TTM)
177.37BINR1.87B · vs all stocks (USD)
Profit Margin
10.14%Beta
0.2600xvs all stocks
52-Week Change
18.36%vs all stocks
Market Capitalization
656.37BINR6.92B · vs all stocks (USD)
Enterprise Value
650.59BINR6.86B · vs all stocks (USD)
Trailing P/E
36.46xForward P/E
23.81xPEG Ratio
0.0392xPrice to Sales (TTM)
3.70xPrice to Book (MRQ)
6.24xEnterprise to Revenue
3.67xEnterprise to EBITDA
13.46xGross Margin
68.31%Profit Margin
10.14%Operating Margin
15.72%Return on Assets (TTM)
6.84%Return on Equity (TTM)
12.96%Revenue (TTM)
177.37BINR1.87B · vs all stocks (USD)
Revenue per Share (TTM)
628.59INRUpdated Sep 29, 2026Quarterly Revenue Growth
23.10%Gross Profit (TTM)
127.59BINR1.34B · vs all stocks (USD)
EBITDA (TTM)
52.97BINR558.21M · vs all stocks (USD)
Net Income (TTM)
17.98BINR189.48M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
930.30%Operating Cash Flow (TTM)
34.45BINR363.07M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
13.62BINR143.53M · vs all stocks (USD)
Trailing Annual Dividend Rate
2.50INRUpdated Sep 29, 2026Trailing Annual Dividend Yield
0.11%vs all stocks
5-Year Average Dividend Yield
0.34%vs all stocks
Payout Ratio
7.85%Minority Interest (Equity)
-3.16MINRFY2026 · Mar 31, 2026Revenue
167.11BINRFY2026 · Mar 31, 2026Cost of Goods Sold
51.14BINRFY2026 · Mar 31, 2026Gross Profit
115.97BINRFY2026 · Mar 31, 2026Operating Income
40.23BINR424.02M · vs all stocks (USD)
Pre-tax Income
19.85BINRFY2026 · Mar 31, 2026Income Tax Expense
6.23BINRFY2026 · Mar 31, 2026Net Income
13.62BINRFY2026 · Mar 31, 2026EBIT
21.93BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
50.57BINRFY2026 · Mar 31, 2026Selling, General & Administrative
18.72BINRFY2026 · Mar 31, 2026Other Operating Expenses
16.08BINRFY2026 · Mar 31, 2026Non-operating Interest Income
413.29MINRFY2026 · Mar 31, 2026Non-operating Interest Expense
2.09BINRFY2026 · Mar 31, 2026EPS (Basic)
48.26INRFY2026 · Mar 31, 2026EPS (Diluted)
48.24INRFY2026 · Mar 31, 2026Basic Shares Outstanding
282.20MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
282.20MSharesFY2026 · Mar 31, 2026Minority Interests (P&L)
-1.01MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
12.93BINRFY2026 · Mar 31, 2026Free Cash Flow
-620.66MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
11.75BINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
19.85BINRFY2026 · Mar 31, 2026Stock-based Compensation
268.05MINRFY2026 · Mar 31, 2026Other Non-cash Items
24.33BINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-17.51BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-14.01BINRFY2026 · Mar 31, 2026Capital Expenditures
-13.55BINRFY2026 · Mar 31, 2026Net Acquisitions
0.00INRFY2026 · Mar 31, 2026Purchase of Investments
-2.40MINRFY2026 · Mar 31, 2026Sale of Investments
480.00KINRFY2026 · Mar 31, 2026Other Investing Activity
308.09MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-13.25BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
0.00INRFY2026 · Mar 31, 2026Long-term Debt Payments
-5.30BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
-17.16BINRFY2026 · Mar 31, 2026Common Dividends Paid
-1.41BINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-23.86BINRFY2026 · Mar 31, 2026Shares Outstanding
282.22MSharesUpdated Sep 29, 2026Float Shares
141.62MSharesUpdated Sep 29, 2026% Held by Insiders
48.96%vs all stocks
% Held by Institutions
27.44%vs all stocks
Total Cash (MRQ)
11.76BINR123.97M · vs all stocks (USD)
Total Cash per Share (MRQ)
41.67INRUpdated Sep 29, 2026Total Debt (MRQ)
5.94BINR62.55M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0565xCurrent Ratio (MRQ)
1.77xBook Value per Share (MRQ)
372.48INRUpdated Sep 29, 2026Total Assets
199.08BINR2.10B · vs all stocks (USD)
Total Current Assets
113.00BINRFY2026 · Mar 31, 2026Total Liabilities
93.96BINRFY2026 · Mar 31, 2026Total Non-current Assets
86.08BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
30.20BINRFY2026 · Mar 31, 2026Total Current Liabilities
63.76BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
11.75BINRFY2026 · Mar 31, 2026Other Short-term Investments
2.26BINRFY2026 · Mar 31, 2026Accounts Receivable
49.63BINRFY2026 · Mar 31, 2026Inventory
34.31BINRFY2026 · Mar 31, 2026Accounts Payable
37.44BINRFY2026 · Mar 31, 2026Short-term Debt
1.07BINRFY2026 · Mar 31, 2026Other Current Liabilities
8.62BINRFY2026 · Mar 31, 2026Long-term Debt
4.86BINRFY2026 · Mar 31, 2026Other Non-current Liabilities
15.36BINRFY2026 · Mar 31, 2026Common Stock (Book)
282.20MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
105.12BINR1.11B · vs all stocks (USD)
52-Week Low
1.79KINRUpdated Sep 29, 202652-Week High
2.54KINRUpdated Sep 29, 202652-Week Change
18.36%vs all stocks
Beta
0.2600xvs all stocks
50-Day MA
2.35KINRUpdated Sep 29, 2026200-Day MA
2.20KINRUpdated Sep 29, 2026Avg 10-Day Volume
535.60KSharesUpdated Sep 29, 2026Avg 30-Day Volume
517.04KSharesUpdated Sep 29, 2026Diluted EPS (TTM)
63.78INRUpdated Sep 29, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.69: safe zoneNotable
Altman Z-Score: 5.69
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $6.92B, above the global median of $1.15BNotable
Market cap (USD): 6,917,482,434.686Global Median: 1,150,342,212.262
Revenue is $1.87B, above the global median of $559.35MNotable
Revenue (USD): 1,869,255,348.83Global Median: 559,350,010.583
Levered free cash flow is $143.53M, above the global median of $18.98MNotable
Levered free cash flow (USD): 143,525,476.89Global Median: 18,979,762.15
Companies that share the same coordination system — how they create, deliver, or capture value.
Amneal Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Huadong Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Immunovant Inc.
Tier 1ProductionApproval-Gated PipelineRule
Alkermes plc
Tier 1ProductionApproval-Gated PipelineRule
Rhythm Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
InnoCare Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Demant A/S
Tier 1ProductionApproval-Gated PipelineFlowRule
Biocon Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Grifols, S.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Samsung Epis Holdings Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk